Also: An experimental gene therapy slowed the progression of Huntington's disease by 75% after three yearsSeptember 24, 2025Check out STAT+Sponsored By NCI/NIH STAT+ | Anthony Letai of Dana-Farber is front-runner to lead National Cancer Institute President Trump is expected to tap a widely respected researcher to lead cancer research at the NCI, sources told STAT. By Matthew Herper and Angus Chen Trump's 'tough it out' to pregnant women meets wave of opposition by medical experts Advising pregnant women not to use Tylenol because of an unproven link to autism overlooks the danger a fever can cause to both mother and fetus. By Elizabeth Cooney, Theresa Gaffney, and Annalisa Merelli STAT+ | FDA's leucovorin approval could be a boon for supplement makers Trump's FDA approval of leucovorin draws parents to folinic acid supplements. Experts caution the doses, quality, and risks aren't the same as the drug By Tara Bannow Justin Sullivan/Getty Images Trump's Tylenol warning cited a Harvard dean's research. But a judge called his shifting conclusions 'unreliable' Andrea Baccarelli was an expert witness in a lawsuit against Tylenol maker. Judge ruled his autism data review was skewed and threw it out By O. Rose Broderick STAT+ | With Trump's anti-vaccine comments, Kennedy's influence grows Standing together at a White House autism event, Trump's anti-vaccine remarks mirrored, and at times exceeded, Kennedy's vaccine policy agenda By Chelsea Cirruzzo and Daniel Payne STAT+ | Acadia Pharmaceuticals drug for rare genetic condition fails late-stage study The treatment did not curb the devastating symptoms of Prader-Willi syndrome in a clinical trial, according to newly released data. By Adam Feuerstein ADOBE STAT+ | Experimental gene therapy for Huntington's markedly slowed disease progression in key trial Results are likely to support the first approval of a genetic treatment for the rare neurodegenerative condition. By Adam Feuerstein More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments